Collectively these results demonstrate that compounds 1, 2 and 4 are cytotoxic agents against CAXII-positive cancer cells and substantially reverse doxorubicin resistance in cancer cells expressing both CAXII and Pgp, but are without significant cytotoxicity in CAXII-negative and not-transformed cells. Here, CA12 is linked to cancer.